Exact Mass: 486.2254
Exact Mass Matches: 486.2254
Found 364 metabolites which its exact mass value is equals to given mass value 486.2254
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Austalide I
Austalide I is a mycotoxin from the food storage mould (Aspergillus ustus Mycotoxin from the food storage mould (Aspergillus ustus).
Antibiotic LL-AB 664
Apadenoson
2-{O3-carbamoyl-2-[(N-formimidoyl-glycyl)-methyl-amino]-beta-D-2-deoxy-gulopyranosylamino}-7-hydroxy-5-methyl-1(3),3a,5,6,7,7a-hexahydro-imidazo[4,5-c]pyridin-4-one
(2S)-5-hydroxy-2-(5-hydroxy-3,4-dimethoxyphenyl)-8-(4-hydroxy-4-methylpentyl)-8-methyl-2,3,7,8-tetrahydropyrano[3,2-g]chromen-4(6H)-one|Tomentin C
2-hydroxy-4-(2-hydroxy-4-methoxy-6-(2-oxoheptyl)benzoyloxy)-6-pentylbenzoic acid
(2S)-5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-8-(4-hydroxy-4-methylpentyl)-8-methyl-2,3,7,8-tetrahydropyrano[3,2-g]chromen-4(6H)-one|Tomentin D
3-deoxo-1,2-dihydro-3-hydroxy-(2beta,3beta)-daphnetoxin
(+)-4-(3-methylbutanoyl)-2,6-di(3,4-dimethoxy)phenyl-3,7-dioxabicyclo[3.3.0]octane
2-methyl-1-[2,4,6-trihydroxy-3-[1-(4-hydroxy-6-methoxy-1,3-benzodioxol-5-yl)-2-methylpropyl]-5-(3-methyl-2-butenyl)phenyl]-1-propanone
C27H34O8_Methyl [(1S,3S,7R,8R,9R,12S,13S)-13-(3-furyl)-6,6,8,12-tetramethyl-17-methylene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.0~1,12~.0~3,8~]heptadec-7-yl](hydroxy)acetate
methyl (2R)-2-[(1S,3S,7R,8R,9R,12S,13R)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]-2-hydroxyacetate
(2R,2R,4aS,6S,7R,8aS)-6,7-diformyl-4-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[benzofuran-2,1-naphthalene]-6,7-diyl diacetate
Ala His Pro Tyr
Ala His Tyr Pro
Ala Asn Pro Trp
Ala Asn Trp Pro
Ala Pro His Tyr
Ala Pro Asn Trp
Ala Pro Trp Asn
Ala Pro Tyr His
Ala Trp Asn Pro
Ala Trp Pro Asn
Ala Tyr His Pro
Ala Tyr Pro His
Glu Glu Ile Pro
Glu Glu Leu Pro
Glu Glu Pro Ile
Glu Glu Pro Leu
Glu Ile Glu Pro
Glu Ile Pro Glu
Glu Leu Glu Pro
Glu Leu Pro Glu
Glu Pro Glu Ile
Glu Pro Glu Leu
Glu Pro Ile Glu
Glu Pro Leu Glu
Phe His Pro Ser
Phe His Ser Pro
Phe Pro His Ser
Phe Pro Ser His
Phe Ser His Pro
Phe Ser Pro His
Gly Pro Gln Trp
Gly Pro Trp Gln
Gly Gln Pro Trp
Gly Gln Trp Pro
Gly Trp Pro Gln
Gly Trp Gln Pro
His Ala Pro Tyr
His Ala Tyr Pro
His Phe Pro Ser
His Phe Ser Pro
His His Pro Pro
His Ile Met Ser
His Ile Ser Met
His Leu Met Ser
His Leu Ser Met
His Met Ile Ser
His Met Leu Ser
His Met Ser Ile
His Met Ser Leu
His Met Thr Val
His Met Val Thr
His Pro Ala Tyr
His Pro Phe Ser
His Pro His Pro
His Pro Pro His
His Pro Ser Phe
His Pro Tyr Ala
His Ser Phe Pro
His Ser Ile Met
His Ser Leu Met
His Ser Met Ile
His Ser Met Leu
His Ser Pro Phe
His Thr Met Val
His Thr Val Met
His Val Met Thr
His Val Thr Met
His Tyr Ala Pro
His Tyr Pro Ala
Ile Glu Glu Pro
Ile Glu Pro Glu
Ile His Met Ser
Ile His Ser Met
Ile Met His Ser
Ile Met Ser His
Ile Pro Glu Glu
Ile Ser His Met
Ile Ser Met His
Leu Glu Glu Pro
Leu Glu Pro Glu
Leu His Met Ser
Leu His Ser Met
Leu Met His Ser
Leu Met Ser His
Leu Pro Glu Glu
Leu Ser His Met
Leu Ser Met His
Met His Ile Ser
Met His Leu Ser
Met His Ser Ile
Met His Ser Leu
Met His Thr Val
Met His Val Thr
Met Ile His Ser
Met Ile Ser His
Met Leu His Ser
Met Leu Ser His
Met Ser His Ile
Met Ser His Leu
Met Ser Ile His
Met Ser Leu His
Met Thr His Val
Met Thr Val His
Met Val His Thr
Met Val Thr His
Asn Ala Pro Trp
Asn Ala Trp Pro
Asn Pro Ala Trp
Asn Pro Trp Ala
Asn Trp Ala Pro
Asn Trp Pro Ala
Pro Ala His Tyr
Pro Ala Asn Trp
Pro Ala Trp Asn
Pro Ala Tyr His
Pro Glu Glu Ile
Pro Glu Glu Leu
Pro Glu Ile Glu
Pro Glu Leu Glu
Pro Phe His Ser
Pro Phe Ser His
Pro Gly Gln Trp
Pro Gly Trp Gln
Pro His Ala Tyr
Pro His Phe Ser
Pro His His Pro
Pro His Pro His
Pro His Ser Phe
Pro His Tyr Ala
Pro Ile Glu Glu
Pro Leu Glu Glu
Pro Asn Ala Trp
Pro Asn Trp Ala
Pro Pro His His
Pro Gln Gly Trp
Pro Gln Trp Gly
Pro Ser Phe His
Pro Ser His Phe
Pro Trp Ala Asn
Pro Trp Gly Gln
Pro Trp Asn Ala
Pro Trp Gln Gly
Pro Tyr Ala His
Pro Tyr His Ala
Gln Gly Pro Trp
Gln Gly Trp Pro
Gln Pro Gly Trp
Gln Pro Trp Gly
Gln Trp Gly Pro
Gln Trp Pro Gly
Ser Phe His Pro
Ser Phe Pro His
Ser His Phe Pro
Ser His Ile Met
Ser His Leu Met
Ser His Met Ile
Ser His Met Leu
Ser His Pro Phe
Ser Ile His Met
Ser Ile Met His
Ser Leu His Met
Ser Leu Met His
Ser Met His Ile
Ser Met His Leu
Ser Met Ile His
Ser Met Leu His
Ser Pro Phe His
Ser Pro His Phe
Thr His Met Val
Thr His Val Met
Thr Met His Val
Thr Met Val His
Thr Val His Met
Thr Val Met His
Val His Met Thr
Val His Thr Met
Val Met His Thr
Val Met Thr His
Val Thr His Met
Val Thr Met His
Trp Ala Asn Pro
Trp Ala Pro Asn
Trp Gly Pro Gln
Trp Gly Gln Pro
Trp Asn Ala Pro
Trp Asn Pro Ala
Trp Pro Ala Asn
Trp Pro Gly Gln
Trp Pro Asn Ala
Trp Pro Gln Gly
Trp Gln Gly Pro
Trp Gln Pro Gly
Tyr Ala His Pro
Tyr Ala Pro His
Tyr His Ala Pro
Tyr His Pro Ala
Tyr Pro Ala His
Tyr Pro His Ala
Austalide I
3,5-O-(1,1,3,3-TETRAISOPROPYL-1,3-DISILOXANEDIYL)URIDINE
2-[5-chloro-2-(4-chlorophenyl)-1H-indol-3-yl]-N,N-dihexylacetamide
[5-[[2-(aminomethylideneamino)acetyl]-methylamino]-4-hydroxy-2-(hydroxymethyl)-6-[(7-hydroxy-5-methyl-4-oxo-3a,6,7,7a-tetrahydro-1H-imidazo[4,5-c]pyridin-2-yl)amino]oxan-3-yl] carbamate
N-[3-[2-(dimethylamino)ethoxy]-4-methoxyphenyl]-4-[2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]benzamide
N-(2,2-Dimethyl-5-morpholin-4-yl-1,4-dihydro-2H-3,7-dithia-6,9,11-triaza-benzo[c]fluoren-8-yl)-N,N-diet hyl-ethane-1,2-diamine
(2S,3S,3aR,9bR)-7-(1-cyclohexenyl)-3-(hydroxymethyl)-1-(4-oxazolylmethyl)-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-7-(cyclohexen-1-yl)-3-(hydroxymethyl)-1-(1,3-oxazol-4-ylmethyl)-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(1R,9S,10S,11S)-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-5-phenyl-12-(pyridin-3-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
(1S,9R,10R,11R)-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-5-phenyl-12-(pyridin-3-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
(2S)-2-[(4R,5S)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(5-pyrimidinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-[(3R,6aR,8R,10aR)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
2-[(3S,6aS,8R,10aS)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
2-[(3R,6aS,8S,10aS)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
(1R,9S,10S,11S)-5-(3-fluorophenyl)-10-(hydroxymethyl)-11-N-(2-methoxyethyl)-6-oxo-12-N-propan-2-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
(1S,9R,10R,11R)-5-(3-fluorophenyl)-10-(hydroxymethyl)-11-N-(2-methoxyethyl)-6-oxo-12-N-propan-2-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
4-Ethoxycarbonyl-3-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]benzoic acid
methyl (2R)-2-[(1S,3S,7R,8R,12S,13S)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]-2-hydroxyacetate
TAN-452
TAN-452 is an orally active, selective peripherally acting δ-opioid receptor (DOR) antagonist with a Ki of 0.47?nM and a Kb of 0.21?nM. TAN-452 is an antagonist for μ-opioid receptor (MOR; Ki=36.56?nM and Kb=9.43?nM) and κ-opioid receptor (KOR; Ki=5.31?nM and Kb=7.18?nM). TAN-452, a derivative of Naltrindole, demonstrates low brain penetrability and attenuates morphine-induced side effects without affecting pain control[1].
methyl (2r)-2-[(1r,2s,5r,6r,13s,14r,16s)-6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]-2-hydroxyacetate
(9r,10r,11s)-19-hydroxy-3,4,5-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(19),2(7),3,5,12,14(18)-hexaen-11-yl 2-methylbutanoate
methyl (2e,3e,5e)-6-[3',3'-dimethyl-5'-(2-methylprop-1-en-1-yl)-3h-spiro[1,4-benzodioxine-2,2'-[1,4]dioxolan]-7-yl]-4-methoxy-2-(methoxymethylidene)-3-methylhexa-3,5-dienoate
(9s)-2,3,6-trihydroxy-4,5-dimethoxy-7-methyl-10-oxo-9h-anthracen-9-yl decanoate
(1r,5s,6r,14r,15s,17r,22s)-10,15-dihydroxy-6,14,18,18,22-pentamethyl-8,19-dioxo-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3,9,11-trien-5-yl acetate
7a,9,11,11b-tetrahydroxy-3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-6,7,9,10,11,12-hexahydro-2,5-dioxatetraphen-1-one
methyl 2-[(1s,3s,5r,7s,8r,10s,12s,13s)-13-(furan-3-yl)-5-hydroxy-6,6,8,12-tetramethyl-17-methylidene-9,15-dioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate
10,15-dihydroxy-6,14,18,18,22-pentamethyl-8,19-dioxo-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3,9,11-trien-5-yl acetate
(+)-4-(3-methylbutanoyl)-2,6-di(3,4-dimeth-oxy)phenyl-3,7-dioxabicyclo[3.3.0]octane
{"Ingredient_id": "HBIN009913","Ingredient_name": "(+)-4-(3-methylbutanoyl)-2,6-di(3,4-dimeth-oxy)phenyl-3,7-dioxabicyclo[3.3.0]octane","Alias": "NA","Ingredient_formula": "C27H34O8","Ingredient_Smile": "CC(C)CC(=O)OC1C2C(COC2C3=CC(=C(C=C3)OC)OC)C(O1)C4=CC(=C(C=C4)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14158","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}